The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...
The vaccine acts like a "wanted poster" unmasking cancer cells that are adept at hiding in the body, only to resurface later.
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
A review of the front page stories from the daily and weekly newspapers in Wales.
A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...